← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
  1. Home
  2. ISRG
  3. P/E History
OverviewAnalysisPriceRevenueEarningsP/ERatiosDividendTargetsShould I Buy?

ISRG logoIntuitive Surgical, Inc. (ISRG) P/E Ratio History

Historical price-to-earnings valuation from 2004 to 2026

Current P/E
57.4
Fair Value
5Y Avg P/E
69.6
-18% vs avg
PE Percentile
15%
Low
PEG Ratio
2.64
Expensive
TTM EPS$8.28
Price$451.73
5Y PE Range49.5 - 85.7
Earnings Yield1.74%

Loading P/E history...

ISRG Valuation Context

How does the current P/E compare to historical and market benchmarks?

vs. 5Y Average
57.4vs69.6
-18%
Cheap vs History
vs. Healthcare
57.4vs22.1
+159%
Above Sector
vs. S&P 500
57.4vs25.2
+128%
Above Market
PEG Analysis
2.64
P/E ÷ EPS Growth
PEG > 2 = Expensive
Based on 23% EPS growth (1Y)
Export Data

P/E Ratio Analysis

As of May 6, 2026, Intuitive Surgical, Inc. (ISRG) trades at a price-to-earnings ratio of 57.4x, with a stock price of $451.73 and trailing twelve-month earnings per share of $8.28.

The current P/E is 18% below its 5-year average of 69.6x. Over the past five years, ISRG's P/E has ranged from a low of 49.5x to a high of 85.7x, placing the current valuation at the 15th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.1x, ISRG trades at a 159% premium to its sector peers. The sector includes 242 companies with P/E ratios ranging from 0.0x to 178.0x.

The PEG ratio of 2.64 (P/E divided by 23% EPS growth) suggests the stock may be expensive relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.

Relative to the broader market, ISRG commands a significant premium over the S&P 500 median P/E of 25.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ISRG DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

ISRG P/E vs Peers

P/E ratio compared to closely matched public peers

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
SYK logoSYKStryker Corporation
$112B34.82.34+8%
MDT logoMDTMedtronic plc
$99B21.5-+31%
BSX logoBSXBoston Scientific Corporation
$83B28.9-+55%
ZBH logoZBHZimmer Biomet Holdings, Inc.
$16B23.3--20%
HOLX logoHOLXHologic, Inc.
$17B30.5--25%
GMED logoGMEDGlobus Medical, Inc.
$12B22.80.73+423%Best
ABT logoABTAbbott Laboratories
$150B11.3Lowest0.38Best+134%
JNJ logoJNJJohnson & Johnson
$541B38.8--58%

Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.

ISRG Historical P/E Data (2004–2026)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterDatePriceTTM EPSP/E Ratiovs Avg
FY2026 Q1$460.99$8.2555.9x+6%
FY2025 Q4Wed Dec 31 2025 00:00:00 GM$566.36$7.8971.8x+36%
FY2025 Q3$447.23$7.5659.2x+12%
FY2025 Q2Mon Jun 30 2025 00:00:00 GM$543.41$7.1775.8x+44%
FY2025 Q1Mon Mar 31 2025 00:00:00 GM$495.27$6.8272.6x+38%
FY2024 Q4$521.96$6.4181.4x+55%
FY2024 Q3Mon Sep 30 2024 00:00:00 GM$491.27$6.2279.0x+50%
FY2024 Q2Sun Jun 30 2024 00:00:00 GM$444.85$5.8276.4x+45%
FY2024 Q1Sun Mar 31 2024 00:00:00 GM$399.09$5.5472.0x+37%
FY2023 Q4Sun Dec 31 2023 00:00:00 GM$337.36$5.0367.1x+27%
FY2023 Q3Sat Sep 30 2023 00:00:00 GM$292.29$4.2568.8x+31%
FY2023 Q2Fri Jun 30 2023 00:00:00 GM$341.94$3.9985.7x+63%

Average P/E for displayed period: 52.6x

Full ISRG Stock Analysis

Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.

View Analysis

Should I Buy ISRG Right Now?

Bull case, key risks, Wall St analyst verdict, and what council investors are saying — updated daily.

See Verdict

See ISRG's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is ISRG Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare ISRG vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

ISRG — Frequently Asked Questions

Quick answers to the most common questions about buying ISRG stock.

Is ISRG stock overvalued or undervalued?

ISRG trades at 57.4x P/E, near its 5-year average of 69.6x. The 15th percentile ranking places valuation within normal historical bounds.

How does ISRG's valuation compare to peers?

Intuitive Surgical, Inc. P/E of 57.4x compares to sector median of 22.1x. The premium reflects expected growth above peers.

What is ISRG's PEG ratio?

ISRG PEG ratio is 2.64. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2004-2026.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

ISRG P/E Ratio History (2004–2026)

P/E ratio calculated as closing price divided by trailing 12-month diluted EPS at each quarter end.